# Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

> **NCT00502099** · PHASE4 · COMPLETED · sponsor: **Amr Hafez** · enrollment: 217 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Pegylated interferon alpha 2a
- **DRUG:** Ribavirin
- **DRUG:** Pegylated interferon alpha 2 b plus ribavirin

## Key facts

- **NCT ID:** NCT00502099
- **Lead sponsor:** Amr Hafez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2012-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502099, "Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00502099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*